These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20503281)

  • 1. Can mucoid Pseudomonas aeruginosa be eradicated in children with cystic fibrosis?
    McPherson H; Rosenthal M; Bush A
    Pediatr Pulmonol; 2010 Jun; 45(6):566-8. PubMed ID: 20503281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009.
    Lillquist YP; Cho E; Davidson AG
    J Cyst Fibros; 2011 May; 10(3):175-80. PubMed ID: 21310671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication of early Pseudomonas aeruginosa infection.
    Høiby N; Frederiksen B; Pressler T
    J Cyst Fibros; 2005 Aug; 4 Suppl 2():49-54. PubMed ID: 16023416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approach to eradication of initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Treggiari MM; Rosenfeld M; Retsch-Bogart G; Gibson R; Ramsey B
    Pediatr Pulmonol; 2007 Sep; 42(9):751-6. PubMed ID: 17647287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
    Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
    Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS
    APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of initial mucoid Pseudomonas aeruginosa in patients with cystic fibrosis.
    Troxler RB; Hoover WC; Britton LJ; Gerwin AM; Rowe SM
    Pediatr Pulmonol; 2012 Nov; 47(11):1113-22. PubMed ID: 22496040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN; Ratjen F
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Greally P; Whitaker P; Peckham D
    Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms.
    Alkawash MA; Soothill JS; Schiller NL
    APMIS; 2006 Feb; 114(2):131-8. PubMed ID: 16519750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection.
    Song Z; Wu H; Mygind P; Raventos D; Sonksen C; Kristensen HH; Høiby N
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3868-74. PubMed ID: 16127064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
    Hansen CR; Pressler T; Koch C; Høiby N
    J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center.
    Denton M; Kerr K; Mooney L; Keer V; Rajgopal A; Brownlee K; Arundel P; Conway S
    Pediatr Pulmonol; 2002 Oct; 34(4):257-61. PubMed ID: 12205566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with mucoid transition of Pseudomonas aeruginosa in cystic fibrosis patients.
    Martha B; Croisier D; Fanton A; Astruc K; Piroth L; Huet F; Chavanet P
    Clin Microbiol Infect; 2010 Jun; 16(6):617-23. PubMed ID: 20002106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis.
    McNamara PS; McCormack P; McDonald AJ; Heaf L; Southern KW
    J Cyst Fibros; 2009 Jul; 8(4):258-63. PubMed ID: 19447080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early antibiotic treatment for eradication of initial infection by Pseudomonas aeruginosa in patients with cystic fibrosis].
    Giugno H; Castaños C; Lubatti A; Pinheiro JL; Hernández C; González Pena H
    Arch Argent Pediatr; 2010 Apr; 108(2):141-7. PubMed ID: 20467710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
    J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa.
    McKay KO; Cooper PJ; van Asperen PP
    J Cyst Fibros; 2009 Dec; 8(6):400-4. PubMed ID: 19716353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.